Exenatide and rare adverse events - PubMed (original) (raw)
. 2008 May 1;358(18):1970-1; discussion 1971-2.
- PMID: 18456920
Exenatide and rare adverse events
Syed R Ahmad et al. N Engl J Med. 2008.
No abstract available
Similar articles
- Exenatide and rare adverse events.
Cure P, Pileggi A, Alejandro R. Cure P, et al. N Engl J Med. 2008 May 1;358(18):1969-70; discussion 1971-2. doi: 10.1056/NEJMc0707137. N Engl J Med. 2008. PMID: 18450614 No abstract available. - Exenatide and acute pancreatitis.
Tripathy NR, Basha S, Jain R, Shetty S, Ramachandran A. Tripathy NR, et al. J Assoc Physicians India. 2008 Dec;56:987-8. J Assoc Physicians India. 2008. PMID: 19322980 - Glucagon-like peptide-1 analogues for type 2 diabetes.
Wilding JP, Hardy K. Wilding JP, et al. BMJ. 2011 Feb 16;342:d410. doi: 10.1136/bmj.d410. BMJ. 2011. PMID: 21325387 No abstract available. - Long-acting glucagon-like peptide 1 receptor agonists: a review of their efficacy and tolerability.
Garber AJ. Garber AJ. Diabetes Care. 2011 May;34 Suppl 2(Suppl 2):S279-84. doi: 10.2337/dc11-s231. Diabetes Care. 2011. PMID: 21525469 Free PMC article. Review. No abstract available. - [Beta-cell function in the foreground. GLP-1 based therapy of type 2 diabetes].
Kern W. Kern W. MMW Fortschr Med. 2010 Jan 14;151 Suppl 4:173-8. MMW Fortschr Med. 2010. PMID: 21595145 Review. German. No abstract available.
Cited by
- The human GLP-1 analog liraglutide and the pancreas: evidence for the absence of structural pancreatic changes in three species.
Nyborg NC, Mølck AM, Madsen LW, Knudsen LB. Nyborg NC, et al. Diabetes. 2012 May;61(5):1243-9. doi: 10.2337/db11-0936. Epub 2012 Feb 14. Diabetes. 2012. PMID: 22338093 Free PMC article. - Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents.
Tatarkiewicz K, Smith PA, Sablan EJ, Polizzi CJ, Aumann DE, Villescaz C, Hargrove DM, Gedulin BR, Lu MG, Adams L, Whisenant T, Roy D, Parkes DG. Tatarkiewicz K, et al. Am J Physiol Endocrinol Metab. 2010 Dec;299(6):E1076-86. doi: 10.1152/ajpendo.00479.2010. Epub 2010 Oct 5. Am J Physiol Endocrinol Metab. 2010. PMID: 20923958 Free PMC article. - Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet.
Rouse R, Zhang L, Shea K, Zhou H, Xu L, Stewart S, Rosenzweig B, Zhang J. Rouse R, et al. PLoS One. 2014 Oct 7;9(10):e109477. doi: 10.1371/journal.pone.0109477. eCollection 2014. PLoS One. 2014. PMID: 25291183 Free PMC article. - Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetes.
Smits MM, Tonneijck L, Muskiet MH, Hoekstra T, Kramer MH, Pieters IC, Cahen DL, Diamant M, van Raalte DH. Smits MM, et al. BMJ Open. 2015 Nov 19;5(11):e009579. doi: 10.1136/bmjopen-2015-009579. BMJ Open. 2015. PMID: 26586327 Free PMC article. Clinical Trial. - SGLT inhibitors as antidiabetic agents: a comprehensive review.
Kshirsagar RP, Kulkarni AA, Chouthe RS, Pathan SK, Une HD, Reddy GB, Diwan PV, Ansari SA, Sangshetti JN. Kshirsagar RP, et al. RSC Adv. 2020 Jan 9;10(3):1733-1756. doi: 10.1039/c9ra08706k. eCollection 2020 Jan 7. RSC Adv. 2020. PMID: 35494673 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical